Showing results (71-80 of 99) with videos related to

Sort By:
Pageof 10
Journal of Enzyme Inhibition and Medicinal Chemistry|January 15, 2024
Identification and evaluation of antiviral activity of novel compounds targeting SARS-CoV-2 virus by enzymatic and antiviral assays, and computational analysisIvana Nemčovičová, Katarína Lopušná, Iveta Štibrániová, et al.
Cancer Research|April 5, 2005
The t(8;9)(p22;p24) is a recurrent abnormality in chronic and acute leukemia that fuses PCM1 to JAK2Andreas Reiter, Christoph Walz, Ann Watmore, et al.
Scientific Reports|August 4, 2021
Macroscale patterns of oceanic zooplankton composition and size structureManoela C Brandão, Fabio Benedetti, Séverine Martini, et al.
Transplantation Proceedings|July 8, 2021
Indocyanine Green Angiography for Quality Assessment of the Kidney During Transplantation: An Outcome Predictor Prospective StudyGiuseppe Ietto, Elia Zani, Fabio Benedetti, et al.
The New England Journal of Medicine|May 14, 2015
Randomized trial of TAS-102 for refractory metastatic colorectal cancerRobert J Mayer, Eric Van Cutsem, Alfredo Falcone, et al.
Blood Advances|August 23, 2021
Lentiviral correction of enzymatic activity restrains macrophage inflammation in adenosine deaminase 2 deficiencyMatteo Zoccolillo, Immacolata Brigida, Federica Barzaghi, et al.
Transplantation Proceedings|November 3, 2021
Predictive Models for the Functional Recovery of Transplanted KidneyGiuseppe Ietto, Luca Guzzetti, Cristiano Salvino Baglieri, et al.
Blood|June 23, 2022
Punctual and kinetic MRD analysis from the Fondazione Italiana Linfomi MCL0208 phase 3 trial in mantle cell lymphomaSimone Ferrero, Daniele Grimaldi, Elisa Genuardi, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|March 30, 2013
Allogeneic hematopoietic cell transplantation from unrelated donors in multiple myeloma: study from the Italian Bone Marrow Donor RegistryRoberto Passera, Simona Pollichieni, Lucia Brunello, et al.
Blood|February 2, 2008
Prospective, multicenter randomized GITMO/IIL trial comparing intensive (R-HDS) versus conventional (CHOP-R) chemoimmunotherapy in high-risk follicular lymphoma at diagnosis: the superior disease control of R-HDS does not translate into an overall survival advantageMarco Ladetto, Federica De Marco, Fabio Benedetti, et al.
Pageof 10